Related Experiment Videos
Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma
Abstract:
We tested 11 patients with choroidal melanomas and 32 control subjects for cell-mediated immunity to melanoma-associated antigens by an in vitro leukocyte migration inhibition assay. Five of seven patients with choroidal melanomas, who received two melanoma extracts used in this series of experiments, had significant leukocyte migration inhibition as compared with none of 17 normal subjects. Four of five melanoma patients who received a third melanoma extract had significant leukocyte migration inhibition as did three of four normal controls, indicating that the extract showed nonspecific inhibition. These data agreed with the concept that patients with choroidal melanomas have cell-mediated immunity to common melanoma-associated antigens.
Insights
Patients with choroidal melanomas show cell-mediated immunity to melanoma antigens. An in vitro leukocyte migration inhibition assay confirmed this immune response in melanoma patients, suggesting potential diagnostic or therapeutic targets.
Area of Science:
- Ophthalmology
- Immunology
- Oncology
Background:
- Choroidal melanomas are the most common primary intraocular malignancy in adults.
- Understanding the immune response in choroidal melanoma is crucial for developing targeted therapies.
- Cell-mediated immunity plays a significant role in anti-tumor responses.
Purpose of the Study:
- To investigate cell-mediated immunity to melanoma-associated antigens in patients with choroidal melanomas.
- To evaluate the utility of the leukocyte migration inhibition assay in assessing this immune response.
Main Methods:
- An in vitro leukocyte migration inhibition assay was performed.
- Eleven patients diagnosed with choroidal melanomas and 32 healthy control subjects were included.
- Patients and controls were exposed to melanoma-associated antigen extracts.
Main Results:
- Seven out of eleven patients with choroidal melanomas demonstrated significant leukocyte migration inhibition when exposed to two specific melanoma extracts.
- None of the 17 control subjects showed significant inhibition with these extracts.
- A third melanoma extract induced significant inhibition in both melanoma patients and normal controls, indicating nonspecificity.
Conclusions:
- The findings support the hypothesis that patients with choroidal melanomas possess cell-mediated immunity against common melanoma-associated antigens.
- The leukocyte migration inhibition assay shows potential for evaluating immune responses in choroidal melanoma.
- Further research is warranted to explore the clinical implications of these findings for diagnosis and treatment.